Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Large Increase in Short Interest

Carl Zeiss Meditec AG (OTCMKTS:CZMWYGet Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totaling 5,102 shares, a growth of 89.7% from the March 31st total of 2,690 shares. Based on an average daily volume of 8,140 shares, the short-interest ratio is currently 0.6 days.

Carl Zeiss Meditec Stock Performance

Shares of OTCMKTS CZMWY opened at $30.89 on Monday. The firm’s 50-day simple moving average is $29.84 and its 200 day simple moving average is $40.55. Carl Zeiss Meditec has a 12-month low of $26.65 and a 12-month high of $75.01.

Analyst Ratings Changes

A number of research firms recently weighed in on CZMWY. The Goldman Sachs Group cut Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. Sanford C. Bernstein cut Carl Zeiss Meditec to a “market perform” rating in a report on Monday, January 26th. One investment analyst has rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold”.

Get Our Latest Report on Carl Zeiss Meditec

Carl Zeiss Meditec Company Profile

(Get Free Report)

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.

See Also

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.